Bayer Considering “Texas Two-Step” Roundup Bankruptcy to Address Non-Hodgkins Lymphoma Lawsuits: Bloomberg
Analysts say the odds are against a Roundup bankruptcy being approved by a federal judge, but the filing could delay cases set for trial throughout 2024.